CLINICAL_TRIALS
trial_result
· 2020-02-21
Clinical Trial Update: A Phase 3 Study of Tanezumab for Chronic Low Back Pain [Phase 3]
Summary
Phase 3 study of tanezumab for chronic low back pain completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-02-21